SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ya-Wen Yang, Chih-Yuan Lee, Rey-Heng Hu, Po-Huang Lee, Meng-Kun Tsai, Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients, Clinical and Experimental Nephrology, 2014, 18, 1, 144

    CrossRef

  2. 2
    M.F. Law, H.K. Lai, H.N. Chan, C.Y. Ha, C. Ng, Y.M. Yeung, S.F. Yip, The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma, European Journal of Cancer Care, 2014, 23, 2
  3. 3
    A. Mekkaoui, Z. Benbrahim, O. Mesbahi, A. Ibrahimi, N. Aqodad, Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse, Journal Africain du Cancer / African Journal of Cancer, 2014, 6, 1, 47

    CrossRef

  4. 4
    Xiang-Yuan Wu, Xing Li, Zhan-Hong Chen, Jing-Yun Wen, Qu Lin, Yan-Fang Xing, Min Dong, Li Wei, Tian-Tian Wang, Jie Chen, Ze-Xiao Lin, Xiang-bo Wan, Dan-Yun Ruan, Xiao-Kun Ma, An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study, Tumor Biology, 2013, 34, 2, 909

    CrossRef

  5. 5
    Yin-Hua Wang, Lei Fan, Li Wang, Run Zhang, Ji Xu, Cheng Fang, Jian-Yong Li, Wei Xu, Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy, Supportive Care in Cancer, 2013, 21, 5, 1265

    CrossRef

  6. 6
    Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila, Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis, Critical Reviews in Oncology/Hematology, 2013, 87, 1, 12

    CrossRef

  7. 7
    Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong, Qiyu Zhang, Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis, Hepatitis Monthly, 2013, 13, 4

    CrossRef

  8. 8
    Thomas Melchardt, Lukas Weiss, Richard Greil, Alexander Egle, Viral infections and their management in patients with chronic lymphocytic leukemia, Leukemia & Lymphoma, 2013, 54, 8, 1602

    CrossRef

  9. 9
    Fan Yang, Huan-Ling Zhu, Chuan He, Jian-Jun Li, Bing Xiang, Xu Cui, Jie Huang, Jie Ji, Hong-Bing Ma, Ting Liu, Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study, Indian Journal of Hematology and Blood Transfusion, 2012,

    CrossRef

  10. 10
    Yi-Hsiang Huang, Han-Chieh Lin, Shou-Dong Lee, Management of chemotherapy-induced hepatitis B virus reactivation, Journal of the Chinese Medical Association, 2012, 75, 8, 359

    CrossRef

  11. 11
    D. H. T. Mya, S. T. Han, Y. C. Linn, W. Y. K. Hwang, Y. T. Goh, D. C. L. Tan, Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection, Annals of Oncology, 2012, 23, 2, 421

    CrossRef

  12. 12
    H.-R. Li, J.-J. Huang, H.-Q. Guo, X. Zhang, Y. Xie, H.-L. Zhu, L.-Z. Zhai, X.-X. Pu, Y. Huang, C.-C. Guo, T.-Y. Lin, Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy, Journal of Viral Hepatitis, 2011, 18, 12
  13. 13
    Pil Soo Sung, Si Hyun Bae, Jeong Won Jang, Do Seon Song, Hee Yeon Kim, Sun Hong Yoo, Chung-Hwa Park, Jung Hyun Kwon, Myeong Jun Song, Chan Ran You, Jong Young Choi, Seung Kew Yoon, Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization, The Korean Journal of Hepatology, 2011, 17, 4, 299

    CrossRef

  14. 14
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  15. 15
    Jorge Méndez-Navarro, Kathleen E. Corey, Hui Zheng, Lydia L. Barlow, Jae Young Jang, Wenyu Lin, Hong Zhao, Run-Xuan Shao, Steven L. McAfee, Raymond T. Chung, Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy, Liver International, 2011, 31, 3
  16. 16
    Samuel E Moses, ZiYi Lim, Mark A Zuckerman, Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients, Expert Review of Anti-infective Therapy, 2011, 9, 10, 891

    CrossRef

  17. 17
    A. M. Evens, B. D. Jovanovic, Y.- C. Su, D. W. Raisch, D. Ganger, S. M. Belknap, M.- S. Dai, B.- C. C. Chiu, B. Fintel, Y. Cheng, S.- S. Chuang, M.- Y. Lee, T.- Y. Chen, S.- F. Lin, C.- Y. Kuo, Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports, Annals of Oncology, 2011, 22, 5, 1170

    CrossRef

  18. 18
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  19. 19
    Mesut Seker, Bala Basak Oven Ustaalioğlu, Ahmet Bilici, Mahmut Emre Yıldırım, Umut Kefeli, Nagehan Ozdemir Barisik, Ismet Tamer, Mahmut Gumus, Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma, Leukemia Research, 2010, 34, 7, e160

    CrossRef

  20. 20
    Michihiro Uchiyama, Yotaro Tamai, Takashi Ikeda, Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma, International Journal of Infectious Diseases, 2010, 14, 3, e265

    CrossRef

  21. 21
    Masaaki Watanabe, Akitaka Shibuya, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Wasaburo Koizumi, Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients, European Journal of Internal Medicine, 2010, 21, 4, 333

    CrossRef

  22. 22
    Philip A. Thompson, Constantine S. Tam, Karin Thursky, John F. Seymour, Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge, Leukemia & Lymphoma, 2010, 51, 9, 1592

    CrossRef

  23. 23
    Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Zeynep Akı, Gülsan Türköz Sucak, Rauf Haznedar, Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies, Hematology, 2010, 15, 4, 240

    CrossRef

  24. 24
    Xing Li, Qu Lin, Min Dong, Jing-Yun Wen, Li Wei, Xiao-Kun Ma, Zhan-Hong Chen, Xiang-Yuan Wu, Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma, Leukemia & Lymphoma, 2010, 51, 9, 1678

    CrossRef

  25. 25
    Eduardo Muñoz Bertrán, Elena Pérez Ceballos, Rosa Gómez Espín, Isabel Ortega González, Reactivación de la hepatitis B en un paciente HBsAg negativo/antiHBc positivo con linfoma B que recibió quimioterapia con rituximab, Gastroenterología y Hepatología, 2010, 33, 5, 377

    CrossRef

  26. 26
    Yutaka Tsutsumi, Reiki Ogasawara, Yusuke Kamihara, Shinichi Ito, Yoshiya Yamamoto, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Rituximab Administration and Reactivation of HBV, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  27. 27
    M. Faraci, B. Cappelli, E. Lanino, G. Morreale, F. Fioredda, C. L. Giudice, R. Giacchino, Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience, Pediatric Transplantation, 2009, 13, 7
  28. 28
    Winnie Yeo, Hepatitis B virus reactivation in association with antineoplastic therapy, Current Hepatitis Reports, 2009, 8, 3, 127

    CrossRef

  29. 29
    Aibin Zhang, Min Zhang, Yan Shen, Weilin Wang, Shusen Zheng, Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation, Clinical Transplantation, 2009, 23, 5
  30. 30
    Yutaka Tsutsumi, Yoshiya Yamamoto, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Nobuo Masauzi, Prevention of hepatitis B virus reactivation under rituximab therapy, Immunotherapy, 2009, 1, 6, 1053

    CrossRef

  31. 31
    Riki Okita, Mamoru Takahashi, Hiroyuki Narahara, Yuichi Sanada, Morihito Okada, Yoshiiku Kawakami, Kazuaki Chayama, Kiwamu Okita, Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy, Clinical Journal of Gastroenterology, 2009, 2, 3, 214

    CrossRef

  32. 32
    J. Montes Santiago, R. Ramos Asensio, Varón de 37 años con fiebre, disfagia y masa mediastínica, Revista Clínica Española, 2009, 209, 11, 550

    CrossRef

  33. 33
    Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng, Pei-Jer Chen, A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial, Hepatology, 2008, 47, 3
  34. 34
    Emmet B. Keeffe, Douglas T. Dieterich, Steven-Huy B. Han, Ira M. Jacobson, Paul Martin, Eugene R. Schiff, Hillel Tobias, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update, Clinical Gastroenterology and Hepatology, 2008, 6, 12, 1315

    CrossRef

  35. 35
    L. H. Katz, A. Fraser, A. Gafter-Gvili, L. Leibovici, R. Tur-Kaspa, Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis, Journal of Viral Hepatitis, 2008, 15, 2
  36. 36
    Roberto J. Firpi, David R. Nelson, Management of viral hepatitis in hematologic malignancies, Blood Reviews, 2008, 22, 3, 117

    CrossRef

  37. 37
    Nancy Leung, Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues, Hepatology International, 2008, 2, 2, 163

    CrossRef

  38. 38
    Yi-Fu He, Yu-Hong Li, Feng-Hua Wang, Wen-Qi Jiang, Rui-Hua Xu, Xiao-Fei Sun, Zhong-Jun Xia, Hui-Qiang Huang, Tong-Yu Lin, Li Zhang, Shi-Ping Bao, You-Jian He, Zhong-zhen Guan, The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma, Annals of Hematology, 2008, 87, 6, 481

    CrossRef

  39. 39
    Omer Junaidi, Adrian M. Di Bisceglie, Aging Liver and Hepatitis, Clinics in Geriatric Medicine, 2007, 23, 4, 889

    CrossRef

  40. 40
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  41. 41
    Christos Emmanouilides, Current treatment options in follicular lymphoma: Science and bias, Leukemia & Lymphoma, 2007, 48, 11, 2098

    CrossRef

  42. 42
    Sammy Saab, Mamie H. Dong, Tom A. Joseph, Myron J. Tong, Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model, Hepatology, 2007, 46, 4
  43. 43
    Feng Wang, Rui-hua Xu, Bing Han, Yan-xia Shi, Hui-yan Luo, Wen-qi Jiang, Tong-yu Lin, Hui-qiang Huang, Zhong-jun Xia, Zhong-zhen Guan, High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers, Cancer, 2007, 109, 7
  44. 44
    Joseph A Sparano, HIV-associated lymphoma: the evidence for treating aggressively but with caution, Current Opinion in Oncology, 2007, 19, 5, 458

    CrossRef

  45. 45
    Nathalie Schnepf, Pierre Sellier, Marc Bendenoun, Jean-Marc Zini, Marie-José Sanson-le pors, Marie-Christine Mazeron, Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy, Journal of Clinical Virology, 2007, 39, 1, 48

    CrossRef

  46. 46
    Gadi Lalazar, Deborah Rund, Daniel Shouval, Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies, British Journal of Haematology, 2007, 136, 5
  47. 47
    Soon-Thye Lim, Gao Fei, Richard Quek, Lay-Cheng Lim, Lai-Heng Lee, Swee-Peng Yap, Susan Loong, Miriam Tao, The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis, European Journal of Haematology, 2007, 79, 2